Jhaveri Jigna Desai, Rush Stephen C, Kostroff Karen, Derisi Dwight, Farber Leonard A, Maurer Virginia E, Bosworth Jay L
Department of Radiation Oncology, Long Island Radiation Therapy, Garden City, NY.
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):859-65. doi: 10.1016/j.ijrobp.2008.01.055. Epub 2008 May 28.
To determine the long-term complication rates and cosmetic results for patients undergoing postmastectomy radiation therapy (PMRT) after immediate reconstruction (IR).
Between January 1998 and December 2005, 92 patients underwent modified radical mastectomy, IR, and PMRT in our practice. A total of 69 patients underwent tissue expander and implant reconstruction (TE/I), and 23 underwent autologous tissue reconstruction (ATR). Follow-up regarding complications and cosmesis was obtained for all 92 patients. Complications were scored as follows: Grade 1, no discomfort; Grade 2, discomfort affecting activities of daily living; Grade 3, surgical intervention or intravenous antibiotics required; and Grade 4, removal or replacement of the reconstruction. Cosmesis was rated as either acceptable or unacceptable to the patient. Both complications and cosmesis were correlated with treatment- and patient-related factors.
Median follow-up for all patients was 38 months. The overall rate of severe complications (Grade 3-4) was 25%. The overall rate of poor functional results (Grade 2-4) was 43.4%. When analyzed as a function of type of reconstruction, the rate of Grade 3 to 4 complications was 33.3% for TE/I vs. 0% for ATR (p = 0.001). The rate of Grade 2 to 4 complications was 55% for TE/I vs. 8.7% for ATR (p < 0.001). Acceptable cosmesis was reported in 51% of TE/I patients vs. 82.6% of ATR patients (p = 0.007). No other treatment or patient-related factors had a significant impact on either complications or cosmesis.
In patients undergoing PMRT after IR, ATR is associated with fewer long-term complications and better cosmetic results than TE/I.
确定即刻乳房重建(IR)后接受乳房切除术后放疗(PMRT)患者的长期并发症发生率及美容效果。
1998年1月至2005年12月期间,我们诊所共有92例患者接受了改良根治性乳房切除术、IR及PMRT。其中69例患者接受了组织扩张器及植入物重建(TE/I),23例接受了自体组织重建(ATR)。对所有92例患者进行了并发症及美容效果方面的随访。并发症评分如下:1级,无不适;2级,不适影响日常生活活动;3级,需要手术干预或静脉使用抗生素;4级,重建物移除或更换。美容效果由患者评定为可接受或不可接受。并发症及美容效果均与治疗相关因素和患者相关因素进行了关联分析。
所有患者的中位随访时间为38个月。严重并发症(3 - 4级)的总体发生率为25%。功能不良结果(2 - 4级)的总体发生率为43.4%。按重建类型分析时,TE/I患者3至4级并发症发生率为33.3%,而ATR患者为0%(p = 0.001)。TE/I患者2至4级并发症发生率为55%,而ATR患者为8.7%(p < 0.001)。51%的TE/I患者报告美容效果可接受,而ATR患者为82.6%(p = 0.007)。没有其他治疗相关因素或患者相关因素对并发症或美容效果有显著影响。
在IR后接受PMRT的患者中,与TE/I相比,ATR的长期并发症更少,美容效果更好。